メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
岡山大学 ホーム
English
日本語
ホーム
プロファイル
研究部門
研究成果
設備
活動
プレス/メディア
受賞
専門知識、名前、または所属機関で検索
Scopus著者プロファイル
長谷川 功
講師
,
岡山大学病院
h-index
217
被引用数
7
h 指数
Pureの文献数とScopusの被引用数に基づいて算出されます
2014
2024
年別の研究成果
概要
フィンガープリント
ネットワーク
研究成果
(74)
類似のプロファイル
(6)
フィンガープリント
Kou Hasegawaが活動している研究トピックを掘り下げます。このトピックラベルは、この研究者の研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。
並べ替え順
重み付け
アルファベット順
Medicine and Dentistry
COVID-19
77%
Symptom
51%
Infection
48%
Acromegaly
45%
Abdominal Pain
36%
Maturity Onset Diabetes of the Young
36%
Adrenal Insufficiency
36%
General Medicine
31%
Pandemic
31%
Elderly Patient
29%
Thyroid Function
29%
Disease
29%
Human Coronavirus NL63
27%
Cryptococcal Meningitis
27%
Mycobacterium genavense
27%
Metastatic Carcinoma
27%
Catecholamine
27%
Nafamstat Mesilate
27%
Autoimmune Pancreatitis
27%
Postcovid Syndrome
27%
Myalgic Encephalomyelitis
27%
Nesidioblastosis
27%
Renal Cyst
27%
Thyroid Crisis
27%
DRESS Syndrome
27%
Infection Complication
27%
Burnout
27%
Bacilli
27%
Fanconi Syndrome
27%
Hypopharyngeal Cancer
27%
Paracentesis
27%
Pembrolizumab
27%
Celiac Artery
27%
Bone Density
27%
Polycystic Kidney Disease
27%
Diabetes Insipidus
27%
Erdheim-Chester Disease
27%
Löffler's Syndrome
27%
Acute Pancreatitis
27%
Streptococcus
27%
Chronic Fatigue Syndrome
27%
Pancreatitis
27%
Colonoscopy
27%
Edema
27%
Daptomycin
27%
Elizabethkingia Meningoseptica
27%
Patient with Type 2 Diabetes
27%
Immunoglobulin G4
27%
Hypoglycemic Coma
27%
Adenomyosis
27%
Keyphrases
Clinical Significance
54%
Rare Complication
34%
Human Coronavirus NL63
27%
Mycobacterium Genavense
27%
Elderly People
27%
Self-rating Depression Scale
27%
Renal Cyst
27%
Drug Rash
27%
General Practice Setting
27%
Drug Hypersensitivity
27%
Late-onset Hypogonadism
27%
Fanconi Syndrome
27%
Inflammatory Response
27%
Low Androgen
27%
Right Shoulder Pain
27%
General Practice
27%
Myxoid Variant
27%
Hairy Kidney
27%
Synchronous Metastases
27%
Metabolic Dysregulation
27%
Prolactin Levels
27%
Type 2 Diabetic Patients
27%
Celiac Artery Dissection
27%
Subcutaneous Edema
27%
Aging
27%
Deceased Donor Kidney Transplantation
27%
COVID-19 Treatment
27%
Isolated Adrenocorticotropin Deficiency
27%
SARS-CoV-2 PCR
27%
Elizabethkingia Meningoseptica
27%
Fosfomycin
27%
Prostate Infection
27%
Dentofacial
27%
Myalgic Encephalomyelitis/chronic Fatigue Syndrome (ME/CFS)
27%
Subclinical Hypothyroidism
27%
Haemophilus Influenzae Infections
27%
Cecal Intubation
27%
Type 2 Diabetes Mellitus (T2DM)
27%
Whole Blood Testing
27%
Granulicatella
27%
Antibody Kinetics
27%
Hypoglycemic Coma
27%
Eosinophilic Pneumonia
27%
Depressive Status
27%
Candida Dubliniensis
27%
Pleuritis
27%
Initial Manifestation
27%
4C Mortality Score
27%
Male Patients
27%
Serum Prolactin Level
27%
Pharmacology, Toxicology and Pharmaceutical Science
Disease
100%
Coronavirinae
86%
Symptom
74%
Gastroesophageal Reflux
54%
Infection
34%
Catecholamine
31%
Randomized Controlled Trial
30%
Pandemic
30%
Nafamstat
27%
Fracture
27%
Androgen
27%
Nafamstat Mesilate
27%
DRESS Syndrome
27%
Noradrenalin
27%
Atypical Mycobacteriosis
27%
Erdheim Chester Disease
27%
Antivirus Agent
27%
Alkaline Phosphatase
27%
Inflammation
27%
Insulinoma
27%
Injury
27%
Elizabethkingia Meningoseptica
27%
Chronic Fatigue Syndrome
27%
Fosfomycin
27%
Subclinical Hypothyroidism
27%
Non Insulin Dependent Diabetes Mellitus
27%
Vaccination Policy
27%
Controlled Clinical Trial
27%
Teprenone
27%
Granulicatella
27%
Myopathy
27%
Adrenal Insufficiency
27%
Prolactin
27%
Growth Hormone
27%
Prevalence
21%
Hypogonadism
18%
Diabetes Mellitus
15%
Testosterone
15%
Hydrocortisone
13%
Replacement Therapy
13%
Epinephrine
11%
Serum Albumin
11%
Liotrix
9%
Hypoglycemia
9%
Histiocytosis
9%
Retroperitoneal Fibrosis
9%
Drug Induced Disease
9%
Connective Tissue Tumor
9%
Hypertension
8%
SARS Coronavirus
7%
